BALTIMORE, MD—Registration is now underway for the certified CME symposium, Evolving Strategies to Improve Patient-Clinician Communication and Treatment Adherence in Multiple Sclerosis. Sponsored by Med-IQ, an ACCME-accredited provider of continuing medical education (CME), this independently supported satellite symposium will be held during the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.
Developed to help neurologists optimize the care of patients with multiple sclerosis (MS), the 1-hour symposium will explore available disease-modifying therapies (DMTs) for the treatment of MS, discuss the importance of adherence, and review patient-focused strategies for overcoming adherence barriers. Presented by a panel of internationally recognized faculty, the symposium will feature real-world clinical case vignettes to help clinicians improve communication and incorporate shared treatment planning into routine practice.
“The recent emergence of novel pharmacotherapies and new formulations of existing agents have ushered in significant advances in MS management. However, incorporating patient perspectives into MS care and developing shared treatment approaches still present challenges for many clinicians,” said Sascha KÃ¶pke, Nursing Research Group, Institute of Social Medicine and Epidemiology at the University of LÃ¼beck. “These are barriers that must be addressed to minimize the impact of the uncertain and variable nature of the disease, the capacity for severe disability, and the pervasive issues of suboptimal treatment adherence.”
The CME symposium will be held in Boston during the 2014 Joint ACTRIMS-ECTRIMS Meeting on Friday, September 12, 2014, at noon in the auditorium of the John B. Hynes Veterans Memorial Convention Center. Interested participants can pre-register by completing this brief online form, calling (toll-free) 866 858 7434, or e-mailing firstname.lastname@example.org of Medicine. “In addition, Dr. Burrow and I will present contemporary evidence that supports emerging therapeutic agents, including alternatives to ERT, for treating patients with Gaucher’s disease
The CME symposium will be held in San Diego during the 64th Annual Meeting of the American Society of Human Genetics (ASHG 2014) on Monday, October 20, 2014, at 6:30 AM in Room 25ABC, Upper Level of the San Diego Convention Center. Interested participants can pre-register by completing this brief online form, calling (toll-free) 866 858 7434, or e-mailing email@example.com.
Sascha Kapke, PhD
Nursing Research Group, Institute of Social Medicine and Epidemiology
University of Läbeck
Fred D. Lublin, MD, FAAN
Saunders Family Professor of Neurology
Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Co-Chief Editor, Multiple Sclerosis and Related Diseases
Icahn School of Medicine at Mount Sinai
New York, NY, USA
Per Soelberg SÃ¸rensen, MD, DMSc, FAAN
Professor of Neurology
University of Copenhagen
Danish Multiple Sclerosis Center, Rigshospitalet
Copenhagen University Hospital
This activity is an independently supported satellite symposium, not included in the formal 2014 Joint ACTRIMS-ECTRIMS accredited program. CME credit provided by Med-IQ. Admittance to this independently supported satellite symposium is only for MS Boston 2014 delegates.
This activity is supported by an educational grant from Teva Pharmaceuticals.
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Med-IQ designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Med-IQ, America’s most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award (2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact:
Senior Audience Development Manager
866 858 7434
Inspiring Medical Education.